Mobile App for Eating Disorders in Adolescents

Status Completed

Clinical Trial Summary

This study aims to evaluate the effectiveness of GGTCA-AD to decrease the maladaptive beliefs associated with eating disorders (ED) in non-clinical adolescent population. Specifically, a randomized controlled trial with parallel design and two groups (experimental and control) will be carried out in adolescents aged 13-15 years to assess the changes pre and post use of the app. It is expected that after the use of the GGTCA-AD app for 14 days, at the primary level, a: decrease in the degree of ascription to dysfunctional beliefs associated with ED; and at the secondary level: increase in body satisfaction and self-esteem; decrease in eating symptomatology; and no changes in emotional symptomatology. These results are also expected to be maintained in subsequent follow-up at 1 month.

Clinical Trial Description

There is a digital platform called GGtude, which is composed of different modules, each of them aimed at working with different mental health problems. The goal is to provide an easy-to-use tool as a CBT complement to work on the self-dialogue that relates to the core beliefs associated with the psychological problem in particular. To achieve this target, a cognitive training exercise is performed: different sentences appear in the form of beliefs, and the person must identify and accept those beliefs that are functional, adaptive and positive, dragging them to the lower part of the screen; and reject those that are dysfunctional, maladaptive and negative dragging them to the upper part of the screen. The GGTCA app is a module of GGtude that was developed to work on dysfunctional beliefs associated with eating disorders. Previous research showed that the app produced a statistically significant decrease of mean scores in maladaptive beliefs associated with ED and a statistically significant increase in self-esteem in adult population. Furthermore, adolescence is a developmental stage vulnerable to the development of these disorders, so it's relevant to adapt the GGTCA application to the adolescent population (GGTCA-AD) and to evaluate its effectiveness. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06039514
Study type	Interventional
Source	University of Valencia
Contact
Status	Completed
Phase	N/A
Start date	April 9, 2024
Completion date	May 23, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04591886` - The Peer-Delivered "Mind. Body. Voice." Program for High School Women	N/A
Completed	`NCT03097874` - Adaptive Treatment for Adolescent Anorexia Nervosa	N/A
Completed	`NCT04591912` - The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote	N/A
Recruiting	`NCT06431854` - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program	N/A
Completed	`NCT05554458` - Implementation and Evaluation of the ChildTaks+ Intervention in the Czech Republic	N/A
Recruiting	`NCT04552639` - Evaluation of Compulsive Exercise Group Therapy for Eating Disorders	N/A
Completed	`NCT05091983` - Restrictive Eating Disorders: From Childhood Orality Disorder to Adolescent Dysensoriality
Active, not recruiting	`NCT04127214` - The ITA Model of Integrated Treatment of Eating Disorders
Completed	`NCT04888273` - Assessing the Feasibility of an Intervention for Youth and Parents Transitioning to Adult Eating Disorder Services	N/A
Recruiting	`NCT03563755` - Social Information Processing in Adolescents With Eating Disorders	N/A
Active, not recruiting	`NCT05780242` - Recrudescence of Eating Conduct Disorders and Covid-19
Active, not recruiting	`NCT03693911` - ACT to Prevent Eating Disorders: Evaluating a Gamified Prevention Program	N/A
Recruiting	`NCT03855553` - Project CORE: Disseminating Eating Disorders Treatment	Phase 1
Completed	`NCT04088097` - Cognitive Behavioral Therapy for Adolescent Binge Eating and Loss of Control Eating	N/A
Completed	`NCT04263155` - The Peer-Delivered Body Project for Young Women in High School	N/A
Enrolling by invitation	`NCT04869423` - Animal-Assisted Therapy in Adolescents With Eating Disorders	N/A
Terminated	`NCT05073679` - Oral Naltrexone In Pediatric Eating Disorders	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.